The 23rd International Workshop on Non-Hodgkin Lymphoma (iwNHL) took place in Boston, MA on September 18–20, 2026. Esteemed experts gathered to discuss the latest research findings in NHL and strategies to enhance patient outcomes. iwNHL 2026 was supported by Platinum Sponsors: AbbVie, AstraZeneca, Genentech, and Genmab; Gold Sponsors: BeOne Medicines and Bristol Myers Squibb; Silver Sponsors: Caribou Biosciences, Eli Lilly and Company, and Novartis; Bronze Sponsors: ADC Therapeutics, Lyell Immunopharma, Natera, Nurix Therapeutics, Regeneron Pharmaceuticals, and Secura Bio; and Supporter: Arvinas. Sponsors of the workshop have no influence over the production of content.
